Progestin effects on expression of AKR1C1–AKR1C3, SRD5A1 and PGR in the Z-12 endometriotic epithelial cell line

article OA: closed CC0 ⤵ 4 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
AI-generated summary by claude@2026-06, 2026-06-07

This study investigated how progestins alter the expression of AKR1C1–AKR1C3, SRD5A1, and PGR in the Z-12 endometriotic epithelial cell line.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

mesh:D004715

MeSH descriptors

20-Hydroxysteroid Dehydrogenases 3-Hydroxysteroid Dehydrogenases 3-Oxo-5-alpha-Steroid 4-Dehydrogenase Endometrium Epithelial Cells Hydroxyprostaglandin Dehydrogenases Membrane Proteins Progestins Receptors, Progesterone 20-Hydroxysteroid Dehydrogenases 20-Hydroxysteroid Dehydrogenases 3-alpha-Hydroxysteroid Dehydrogenase (B-Specific) 3-Hydroxysteroid Dehydrogenases 3-Hydroxysteroid Dehydrogenases 3-Hydroxysteroid Dehydrogenases 3-Oxo-5-alpha-Steroid 4-Dehydrogenase 3-Oxo-5-alpha-Steroid 4-Dehydrogenase 3-Oxo-5-alpha-Steroid 4-Dehydrogenase Aldo-Keto Reductase Family 1 Member C3 Cells, Cultured

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (37)

Cited by (4)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:15:58.344756+00:00
License: CC0 · commercial use OK